Tresiba (insulin degludec) U-200

insulin degludec · Novo Nordisk A/S

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Tresiba (insulin degludec) U-200, covering 2015-11-18 to 2015-11-18. Get the full timeline:

Most recent: Clinical Trial Update: Comparison of Two Insulin Degludec Formulations in Subjects With Type 2 Diabetes Mellitus [Phase 3]